Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Virology

• Publication date

  1987-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0042-6822(87)90326-6PMID 3029956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The preparation of purified bluetongue virus group antigen for use as a diagnostic reagent

  2005cited by this paper
• Uncoating of parental bluetongue virus to core and subcore particles in infected L cells.

  1987cited by this paper
• Newer directions in vaccine development and utilization.

  1985cited by this paper
• Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation.

  1985cited by this paper
• Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation.

  1985cited by this paper
• General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes

  1984cited by this paper
• Synthetic viral vaccines.

  1984cited by this paper
• Purification of the group-specific antigen of bluetongue virus by chromatofocusing.

  1983cited by this paper
• Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody

  1983cited by this paper
• Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants.

  1983cited by this paper
• Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

  1982cited by this paper
• Purification and characterization of bovine rotavirus cores

  1982cited by this paper
• Identification of the serotype-specific and group-specific antigens of bluetongue virus.

  1981cited by this paper
• A haemagglutination and haemagglutination inhibition test for bluetongue virus.

  1980cited by this paper
• The in vitro activation and further characterization of the bluetongue virus-associated transcriptase.

  1980cited by this paper
• Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes.

  1980cited by this paper
• A haemagglutination and haemagglutination inhibition test for bluetongue virus.

  1980cited by this paper
• Protein synthesis in bluetongue virus-infected cells.

  1979cited by this paper
• The elimination of ribonucleic acid interference in the spectrophotometric determination of protein concentration.

  1974cited by this paper
• Spectrophotometric determination of protein concentration in cell extracts containing tRNA's and rRNA's.

  1973cited by this paper
• Structure of the Bluetongue Virus Capsid

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• TYPES OF ACQUIRED IMMUNITY AGAINST INFECTIOUS DISEASE

  1949cited by this paper

• Plasmid DNA-based reverse genetics as a platform for manufacturing of bluetongue vaccine

  2025cites this paper
• Evaluating Temperature Effects on Bluetongue Virus Serotype 10 and 17 Coinfection in Culicoides sonorensis

  2024cites this paper
• Increased Clinical Signs and Mortality in IFNAR(−/−) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype

  2023cites this paper
• In Situ Hybridization (RNAscope) Detection of Bluetongue Virus Serotypes 10 and 17 in Experimentally Co-Infected Culicoides sonorensis

  2023cites this paper
• Recovery of multireassortant bluetongue virus serotype 6 sequences from a mule deer (Odocoileus hemionus) and Dorset sheep (Ovis aries) in Colorado.

  2023cites this paper
• The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge

  2021cites this paper
• The Interplay between Bluetongue Virus Infections and Adaptive Immunity

  2021cites this paper
• Safety and efficacy of a Bluetongue inactivated vaccine (serotypes 1 and 4) in sheep.

  2021cites this paper
• A protective bivalent vaccine against Rift Valley fever and bluetongue

  2020cites this paper
• Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes

  2020influential citation
• A protective bivalent vaccine against Rift Valley fever and bluetongue

  2020cites this paper
• Alternative methods to reduce the animal use in quality controls of inactivated BTV8 Bluetongue vaccines.

  2020cites this paper
• Production and Easy One-Step Purification of Bluetongue Recombinant VP7 from Infected Sf9 Supernatant for an Immunoenzymatic Assay (ELISA)

  2020cites this paper
• Evaluation of A Baculovirus-Expressed VP2 Subunit Vaccine for the Protection of White-Tailed Deer (Odocoileus virginianus) from Epizootic Hemorrhagic Disease

  2020cites this paper
• Ecological Dynamics Impacting Bluetongue Virus Transmission in North America

  2020cites this paper
• Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice

  2019cites this paper
• Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR (cid:1) / (cid:1) mice

  2019cites this paper
• Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.

  2018cites this paper
• New generation vaccines against bluetongue virus

  2018cites this paper
• Isolation and molecular characterization of bluetongue virus from Southern India

  2018cites this paper
• Analysis of Conserved, Computationally Predicted Epitope Regions for VP5 and VP7 Across three Orbiviruses

  2018cites this paper
• Solubilisation and purification of recombinant bluetongue virus VP7 expressed in a bacterial system.

  2018cites this paper
• Genetic and phylogenetic analysis of the outer capsid protein genes of Indian isolates of bluetongue virus serotype-16

  2018cites this paper
• CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR−/− Mice

  2018cites this paper
• In-silico approach to determine the possibility of a recombinant broad-spectrum vaccine for bluetongue disease

  2018influential citation
• Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations

  2017influential citation
• B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera

  2017influential citation
• Bluetongue: Aetiology, Epidemiology, Pathogenesis, Diagnosis and Control

  2017cites this paper
• Investigating the transmission of epizootic hemorrhagic disease virus (EHDV) among white-tailed deer in Alabama

  2017cites this paper
• Development of plant-produced protein body vaccine candidates for bluetongue virus

  2017cites this paper
• Desarrollo de vacunas recombinantes marcadoras multiserotipo frente al virus de la lengua azul

  2017influential citation
• Bluetongue Virus: From BTV-1 to BTV-27.

  2017cites this paper
• Identifying B-cell epitopes of African horse sickness virus serotype 4 recognised by antisera of immunised horses

  2016cites this paper
• Defeating Bluetongue virus: new approaches in the development of multiserotype vaccines

  2016cites this paper
• Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro

  2016cites this paper
• African horse sickness virus infects BSR cells through macropinocytosis.

  2016cites this paper
• Effect of Viral Antigen Levels on the Serological Response and Efficiency of the Binary Ethylenimine-Inactivated Bluetongue Virus Serotype-16 Vaccine

  2016cites this paper
• Molecular characterisation of epizootic haemorrhagic disease virus associated with a Tunisian outbreak among cattle in 2006.

  2016cites this paper
• Recovery of an African horsesickness virus VP2 chimera using reverse genetics

  2016cites this paper
• A Review of Knowledge Gaps and Tools for Orbivirus Research

  2015cites this paper
• An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice.

  2015cites this paper
• Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine

  2015influential citation
• Atomic model of a non-enveloped virus reveals pH sensors for a coordinated process of cell entry

  2015cites this paper
• Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.

  2015cites this paper
• Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses

  2015cites this paper
• VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV

  2015cites this paper
• Development and evaluation of a subunit DIVA vaccine against bluetongue virus serotype 8 in cattle

  2014cites this paper
• The molecular biology of Bluetongue virus replication.

  2014cites this paper
• Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.

  2014cites this paper
• Evidence for Transmission of Bluetongue Virus Serotype 26 through Direct Contact

  2014cites this paper
• The susceptibility of Culicoides imicola and Culicoides oxystoma

  2014cites this paper
• Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.

  2014cites this paper
• Recombinant vaccines against bluetongue virus.

  2014cites this paper
• Culicoides Midge Bites Modulate the Host Response and Impact on Bluetongue Virus Infection in Sheep

  2014cites this paper
• Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus

  2014cites this paper
• Virus Serotype 8 in Cattle Vaccinated Animals against Bluetongue Differentiation between Infected and Experimental Subunit Vaccine That Allows Evaluation of the Immunogenicity of an

  2014cites this paper
• The immune response of ruminant livestock to bluetongue virus: from type I interferon to antibody.

  2014cites this paper
• Development of plant-produced Bluetongue virus vaccines

  2014influential citation
• Serological and genetic characterisation of putative new serotypes of bluetongue virus and epizootic haemorrhagic disease virus isolated from an Alpaca

  2014cites this paper
• Identification and expression of proteases C. sonorensis and C. imicola important for African horsesickness virus replication

  2014cites this paper
• Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection

  2014cites this paper
• Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

  2013cites this paper
• Development of Safe and Efficacious Bluetongue Virus Vaccines

  2013cites this paper
• Evaluation of the Immunogenicity of an Experimental Subunit Vaccine That Allows Differentiation between Infected and Vaccinated Animals against Bluetongue Virus Serotype 8 in Cattle

  2013cites this paper
• Identification of three novel linear B-cell epitopes on the VP5 protein of BTV16.

  2013cites this paper
• Assessment of BTV VP7-169 as a vector for the display of foreign peptides

  2013cites this paper
• Transplacental infection in goats experimentally infected with a European strain of bluetongue virus serotype 8.

  2013cites this paper
• Bluetongue virus serotype 26: infection kinetics, pathogenesis and possible contact transmission in goats.

  2013cites this paper
• Serotype- and serogroup-specific detection of African horsesickness virus using phage displayed chicken scFvs for indirect double antibody sandwich ELISAs

  2013influential citation
• A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles.

  2013cites this paper
• History of Orbivirus research in South Africa.

  2012cites this paper
• Bluetongue virus serotype 26: infection kinetics and pathogenesis in Dorset Poll sheep.

  2012cites this paper
• Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.

  2012cites this paper
• Structural Insight into African Horsesickness Virus Infection

  2012cites this paper
• Virus-specific CD8⁺ T-cells detected in PBMC from horses vaccinated against African horse sickness virus.

  2012cites this paper
• Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8

  2012cites this paper
• Development and evaluation of a real-time polymerase chain reaction assay for equine encephalosis virus

  2012cites this paper
• Establishment of the viral nature of the aetiological agent

  2012cites this paper
• Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

  2012cites this paper
• Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.

  2012cites this paper
• Assessment of vaccine delivery systems and their impact on the enhancement of immunogenicity, potency and safety of specific livestock vaccines used in South Africa

  2012cites this paper
• Rescue of Recent Virulent and Avirulent Field Strains of Bluetongue Virus by Reverse Genetics

  2012cites this paper
• Horsesickness Virus Infection Structural Insight into African

  2012cites this paper
• Vaccins de recombinaison du virus de la fievre catarrhale et utilisations de ceux-ci

  2011cites this paper
• Solubility, particle formation and immune display of trimers of major capsid protein 7 of African horsesickness virus fused with enhanced green fluorescent protein

  2011influential citation
• Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus Challenge

  2011cites this paper
• Infection kinetics of Epizootic Haemorrhagic Disease virus serotype 6 in Holstein-Friesian cattle.

  2011cites this paper
• Expression and characterization of full length and truncated versions of major outercapsid protein VP2 of bluetongue virus in bacterial and insect cells

  2011cites this paper
• Development of a single real-time RT-PCR method for the group-specific identification of African horsesickness virus and bluetongue virus

  2011cites this paper
• Saliva Proteins of Vector Culicoides Modify Structure and Infectivity of Bluetongue Virus Particles

  2011cites this paper
• Standardization and validation of an immunoperoxidase test for African horsesickness virus using formalin-fixed, paraffin-embedded tissues

  2011cites this paper
• Oncolytic Bluetongue Viruses: Promise, Progress, and Perspectives

  2011cites this paper
• A novel method for purifying bluetongue virus with high purity by co-immunoprecipitation with agarose protein A

  2010cites this paper
• Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep.

  2010cites this paper
• Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4.

  2010cites this paper
• Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

  2010cites this paper
• Detection of bluetongue virus group-specific antigen using monoclonal antibody based sandwich ELISA

  2010cites this paper
• RT-PCR Assays for Seven Serotypes of Epizootic Haemorrhagic Disease Virus & Their Use to Type Strains from the Mediterranean Region and North America

  2010cites this paper
• Intragenic Recombination as a Mechanism of Genetic Diversity in Bluetongue Virus

  2010cites this paper
• Tubules composed of non-structural protein NS1 of african horsesickness virus as system for the immune display of foreign peptides

  2010cites this paper